Table 5. NEI VFQ-25 overall composite score and subscale scores for the present study and previously published studies, mean (SD).
| Study | Group composition | Age | GH | GV | OP | NA | DA | VSSF | VSMH | VSRD | VSD | D | CV | PV | OCS |
| Van de Put | RRD mac-off | 60.4 (11.2) | 60.5 | 71.3 | 88.4 | 85.6 | 86.1 | 98.4 | 87.6 | 88.2 | 98.3 | 84.2 | 97.0 | 91.0 | 88.9 |
| n = 55 | 12 months | (21.3) | (12.0) | (15.2) | (13.8) | (12.6) | (4.8) | (14.7) | (16.2) | (5.4) | (17.1) | (13.0) | (16.3) | (7.9) | |
| Okamoto [18] | RRD mac-on & off | 52.3 (13.2) | 54.2 | 70.7 | 82.4 | 75.3 | 75.6 | 88.2 | 77.5 | 78.5 | 87.2 | 75.5 | 94.0 | 72.2 | 79.6 |
| n = 55 | 3 months | (16.6) | (14.9) | (14.7) | (17.3) | (16.9) | (14.9) | (18.4) | (24.3) | (17.3) | (24.0) | (10.8) | (21.0) | (14.2) | |
| Okamoto [19] | RRD mac-on & off | 51.9 (13.8) | 54.4 | 71.3 | 83.3 | 76.6 | 76.3 | 89.2 | 78.2 | 79.2 | 88.1 | 77.0 | 94.1 | 72.5 | 80.3 |
| n = 51 | 6 months | (17.1) | (13.4) | (13.2) | (16.1) | (15.8) | (13.5) | (17.2) | (22.0) | (15.3) | (22.0) | (10.7) | (20.2) | (12.5) | |
| Schweitzer [32] | Acute PVD | Females: 62.1 (7.6) | 80.6 | 85.8 | 89.6 | 89.6 | 94.4 | 99.1 | 91.8 | 95.7 | 99.4 | 87.9 | 99.1 | 95.5 | 93.5 |
| n = 84 | 6 weeks | Males: 64.5 (6.6) | (16.0) | (10.9) | (12.9) | (10.9) | (8.3) | (3.4) | (9.8) | (8.6) | (3.0) | (14.6) | (6.1) | (11.1) | (6.2) |
| Okamoto [19] | MH | 64.3 (9.6) | 53.6 | 69.0 | 84.8 | 70.2 | 72.2 | 82.7 | 76.6 | 78.6 | 85.7 | 78.6 | 85.7 | 75.8 | 79.2 |
| n = 42 | 3 months | (17.1) | (14.1) | (16.0) | (18.8) | (19.4) | (15.6) | (14.1) | (21.8) | (19.2) | (12.6) | (19.2) | (19.3) | (13.0) | |
| Hirneiss [33] | MH | 67 (-) | 61.1 | 62.6 | 88.0 | 71.3 | 80.0 | 84.7 | 88.5 | 71.1 | 88.7 | 66.8 | 92.1 | 85.8 | 79.1 |
| n = 59 | 3 months | (18.4) | (21.6) | (18.0) | (20.4) | (20.1) | (18.6) | (19.8) | (28.2) | (18.7) | (30.5) | (10.4) | (20.5) | (15.4) | |
| Tranos [34] | MH | 70 (9) | 64.2 | 70.5 | 84.1 | 77.2 | 81.1 | 92.1 | 74.7 | 74.5 | 88.8 | 82.6 | 95.8 | 88.3 | 82.4 |
| n = 26 | 4 months | (18.2) | (14.5) | (20.4) | (22.8) | (20.8) | (17.5) | (27.4) | (26.6) | (19.5) | (29.3) | (13.2) | (20.1) | (14.1) | |
| Okamoto [19] | ERM | 67 (8.4) | 55.3 | 69.1 | 87.9 | 71.0 | 73.4 | 83.0 | 78.4 | 76.5 | 88.9 | 76.0 | 89.4 | 72.7 | 78.5 |
| n = 33 | 3 months | (15.0) | (11.3) | (11.9) | (18.2) | (16.0) | (9.3) | (13.1) | (20.0) | (11.0) | (16.9) | (12.5) | (17.0) | (8.4) | |
| Ghazi [35] | ERM | 66 (13) | 65.8 | 70.5 | 86.8 | 74.6 | 79.4 | 94.7 | 79.5 | 80.6 | 91.2 | 88.0 | 92.1 | 86.1 | 83.3 |
| n = 20 | 4 months | (27.9) | (12.2) | (18.4) | (24.4) | (18.3) | (12.7) | (22.7) | (26.5) | (17.0) | (8.4) | (11.9) | (23.0) | (15.5) | |
| Matsuoka [36] | ERM | 70 (9) | 61 | 68 | 84 | 78 | 77 | 85 | 78 | 85 | 90 | 71 | 89 | 71 | 81 |
| n = 26 | 12 months | (2) | (3) | (3) | (2) | (3) | (2) | (4) | (3) | (3) | (4) | (3) | (4) | (2) |
VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General vision, OP: Ocular pain, NA: Near activities, DA: Distance activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, SD: standard deviation, RRD: rhegmatogenous retinal detachment, PVD: posterior vitreous detachment, MH: macular hole, ERM: epiretinal membrane.